The Rising Tide of Cardiovascular Risk in Younger Women

Menopause management is in the midst of a paradigm shift as enthusiasm, fueled by the lay press and online influencers, increases amongst women, yielding an escalating interest in hormone therapy (HT) that has not been experienced since the turn of the last century. Updates to regulatory labeling of menopausal HT products include the removal of boxed warnings and language that recommended using the lowest dose for the shortest time while focusing on risks and benefits to those seeking menopause symptom relief-women younger than 60 or within 10 years of menopause. This renewed desire for menopausal HT must be tempered with the understanding that risks for cardiovascular disease (CVD) are also rising in premenopausal women as are hospitalizations for acute coronary syndromes. Factors that contribute to long-term cardiovascular risk include adverse pregnancy outcomes, which are occurring with increasing frequency. The metabolic changes that accompany the menopause transition further complicate a woman's cardiovascular risk profile. Many women today will arrive at menopause with more advanced CVD risk than what was encountered in the past. If women are considering HT for menopausal symptom relief or bone preservation, careful consideration is required to identify and treat modifiable CVD risks-dyslipidemia, glucose intolerance, hypertension, and, increasingly, obesity-to targets established by guidelines before initiating HT. Risk assessment with validated risk calculators can help stratify CVD risk, a factor that determines lipid lowering therapy, and the advisability and choice of menopausal HT. The rising tide of cardiovascular risk does not have to make waves at menopause.

Authors

Institutions

Publication Details

Journal
Obstetrics and Gynecology
Published
2026-11-17
DOI
https://doi.org/10.1097/aog.0000000000006471
Primary Topic
Menopause: Health Impacts and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Rising Tide of Cardiovascular Risk in Younger Women

Cynthia A. Stuenkel
3 links
Obstetrics and Gynecology
Menopause: Health Impacts and Treatments
article

The Rising Tide of Cardiovascular Risk in Younger Women

Cynthia A. Stuenkel
article en

Abstract

Menopause management is in the midst of a paradigm shift as enthusiasm, fueled by the lay press and online influencers, increases amongst women, yielding an escalating interest in hormone therapy (HT) that has not been experienced since the turn of the last century. Updates to regulatory labeling of menopausal HT products include the removal of boxed warnings and language that recommended using the lowest dose for the shortest time while focusing on risks and benefits to those seeking menopause symptom relief-women younger than 60 or within 10 years of menopause. This renewed desire for menopausal HT must be tempered with the understanding that risks for cardiovascular disease (CVD) are also rising in premenopausal women as are hospitalizations for acute coronary syndromes. Factors that contribute to long-term cardiovascular risk include adverse pregnancy outcomes, which are occurring with increasing frequency. The metabolic changes that accompany the menopause transition further complicate a woman's cardiovascular risk profile. Many women today will arrive at menopause with more advanced CVD risk than what was encountered in the past. If women are considering HT for menopausal symptom relief or bone preservation, careful consideration is required to identify and treat modifiable CVD risks-dyslipidemia, glucose intolerance, hypertension, and, increasingly, obesity-to targets established by guidelines before initiating HT. Risk assessment with validated risk calculators can help stratify CVD risk, a factor that determines lipid lowering therapy, and the advisability and choice of menopausal HT. The rising tide of cardiovascular risk does not have to make waves at menopause.

Obstetrics and Gynecology
University of California San Diego (US)
Good health and well-being
Menopause: Health Impacts and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon